GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 209 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $33,000 | +17.9% | 285 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $28,000 | -20.0% | 285 | 0.0% | 0.01% | -25.0% |
Q2 2020 | $35,000 | +25.0% | 285 | -12.3% | 0.01% | +14.3% |
Q1 2020 | $28,000 | -15.2% | 325 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $33,000 | -10.8% | 325 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $37,000 | -2.6% | 325 | +20.4% | 0.01% | -22.2% |
Q2 2019 | $38,000 | -30.9% | 270 | -16.9% | 0.01% | -10.0% |
Q1 2019 | $55,000 | +71.9% | 325 | 0.0% | 0.01% | +42.9% |
Q4 2018 | $32,000 | -42.9% | 325 | 0.0% | 0.01% | -36.4% |
Q3 2018 | $56,000 | +51.4% | 325 | +20.4% | 0.01% | +37.5% |
Q2 2018 | $37,000 | +37.0% | 270 | +12.5% | 0.01% | +33.3% |
Q1 2018 | $27,000 | +3.8% | 240 | +9.1% | 0.01% | 0.0% |
Q4 2017 | $26,000 | – | 220 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |